Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
3.350
-0.190 (-5.37%)
At close: Sep 1, 2026, 4:00 PM EDT
3.280
-0.070 (-2.09%)
Pre-market: Sep 2, 2026, 6:18 AM EDT
Jupiter Neurosciences Market Cap
Jupiter Neurosciences has a market cap or net worth of $2.58 million as of September 2, 2026. Its market cap has decreased by -94.96% in one year.
Market Cap
2.58M
Enterprise Value
2.81M
1-Year Change
-94.96%
Ranking
Category
Stock Price
$3.35
ChartMarket Cap Chart
Since the IPO on December 3, 2024, Jupiter Neurosciences's market cap has decreased from $132.40M to $2.58M, a decrease of -98.05%. That is a compound annual growth rate of -89.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 2.58M | -92.65% |
| Dec 31, 2025 | 35.11M | -90.09% |
| Dec 31, 2024 | 354.21M | 167.54% |
| Dec 3, 2024 | 132.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Artelo Biosciences | 3.01M |
| Curis | 3.01M |
| Clearmind Medicine | 2.91M |
| Matinas BioPharma Holdings | 2.89M |
| BioAtla | 2.89M |
| Onconetix | 2.45M |
| Virax Biolabs Group | 2.25M |
| Oragenics | 2.23M |